NPM1 p.W288Cfs*12
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Ziftomenib | |
| FDA (2) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Revumenib |